OncoPro

History

2025: Acquisition of official medical device status

In May 2025, it became known that Sechenov University received a state registration certificate for the Onkopro software, designed for the early diagnosis of cancer. The system officially received the status of a medical device and was approved for use in clinical practice. The development allows determining the probability of the risk of six malignancies based on a blood test and mathematical data processing methods.

According to "," Kommersant the work on the system was jointly carried out by specialists from the Institute of Personalized Oncology of Sechenov University and the RAS V.P. Ivannikov Institute for System Programming. The software determines the probability of having,, lung cancer,,, and kidneys breast. ovary prostate For colorectal cancer calculation, data on 12 tumor markers obtained from the patient's blood test are used.

𝓲

Фото: Sechenov University

The development was tested at the university's clinical center for several years, which made it possible to verify the accuracy and reliability of the algorithms used. In the future, the developers intend to expand the list of types of cancer, the risk of which can be determined by the Onkopro system.

The system uses machine learning and artificial intelligence techniques to analyze blood biomarkers. To create the method, data from 600 patients treated at the university clinics were used. Artificial intelligence has provided scientists with a complete picture of changes in biomarkers characteristic of various types of cancer.

The scientific group of Sechenov University has already filed four patent applications under the developed system. Currently, methods for diagnosing lung and colon cancer have been patented. The text of the patent states that the new method allows not only to identify oncology at an early stage, but also to increase the accuracy of screening.^[1]

Notes